Sleep Problems in Intellectual Disability: The Clinical Question
Sleep problems in people with intellectual disability are persistent or clinically significant difficulties with falling asleep, staying asleep, sleeping at appropriate times, breathing normally during sleep, obtaining restorative rest, or remaining alert during the day. They can arise from interacting medical, neurologic, circadian, psychological, environmental, and behavioral factors. Effective care begins by identifying the particular sleep problem and its contributors, assessing the person's health and communication needs, and selecting individualized interventions whose effects can be measured. Sleep difficulties deserve the same clinical attention in people with intellectual disability as in everyone else. Perera and O'Regan, 2024; NICE NG11.
Intellectual disability describes significant limitations in intellectual functioning and adaptive behavior originating during the developmental period. Conceptual, social, and practical adaptive skills may affect how a person describes sleep, understands an unfamiliar test, establishes routines, or accesses a sleep clinic. These differences influence the assessment process; they do not determine a single sleep phenotype or imply that poor sleep is inevitable. A person may reliably identify fatigue and pain, communicate through speech or augmentative and alternative communication, or rely partly on observations from a trusted supporter. Clinical practice should recognize each route to valid information. AAIDD defining criteria.
The practical question is more precise than whether a person “sleeps badly.” Is there prolonged sleep onset, repeated waking, early awakening, an irregular day-night schedule, snoring and breathing interruption, distressing nighttime behavior, hypersomnolence, or a new change from the person's usual pattern? A useful evaluation then asks whether pain, seizures, constipation, reflux, anxiety, medication, environmental conditions, or a specific sleep disorder account for the complaint. Because several contributors often coexist, identifying one does not end the assessment. NICE NG54; Perera and O'Regan, 2024.
How Common Are Sleep Difficulties?
Studies consistently identify a substantial burden of sleep problems among people with intellectual and developmental disabilities, but the estimated frequency depends strongly on age, syndrome, service setting, definition, and assessment method. A systematic review of 50 studies involving adults with intellectual disability reported prevalence estimates ranging from 8.5% to 34.1%; approximately 9.2% was reported for significant sleep problems in one estimate. The review emphasized substantial methodological variation and cautioned that most associations were observational. Such figures summarize particular studies, not a universal risk for any individual. Van de Wouw and colleagues, 2012.
Children with different neurodevelopmental and genetic conditions also show elevated rates of sleep complaints compared with typically developing comparison groups. The size and pattern of the difference varies markedly by diagnosis. A meta-analysis of rare genetic syndromes found distinct distributions of insomnia, sleep-disordered breathing, and daytime sleepiness across syndromes. These studies are clinically useful for deciding what to investigate, but they cannot replace an individualized sleep history or justify assuming that all people with a particular condition have the same biological mechanism. Agar and colleagues, 2021; Esbensen and Schwichtenberg, 2016.
Sleep outcomes also depend on whose report is obtained. Some people can describe restless sleep or vivid nighttime experiences while a caregiver chiefly observes awakenings or activity. Other people sleep alone and their disruptions may be missed. Daytime irritability can be visible while nocturnal breathing problems remain unrecognized. Reports from the person, family, residential staff, and objective measures offer complementary perspectives when collected respectfully and interpreted together.
Types of Sleep Problems and Their Different Meanings
Difficulty Falling Asleep or Staying Asleep
Insomnia symptoms include excessive time spent trying to fall asleep, repeated or prolonged waking after sleep onset, and waking too early with an inability to return to sleep. Clinical insomnia disorder additionally requires appropriate duration, frequency, adequate opportunity to sleep, daytime consequences, and professional diagnostic evaluation. In intellectual disability, daytime consequences may appear as reduced concentration, less engagement, distress, diminished daily living performance, or fatigue reported in the person's own terms. Nighttime wakefulness recorded by a staff member alone does not establish a disorder without the broader clinical context. American College of Physicians insomnia guideline.
Sleep-onset difficulty may occur when scheduled bedtime precedes the person's natural sleep phase, when the day contains little activity or light exposure, or when worry, sensory discomfort, or conditioned arousal makes the bedroom an unsettling environment. Night waking may be driven by untreated pain, nocturia, obstructive breathing, seizures, noise, or an association between returning to sleep and particular adult assistance. A functional account distinguishes these pathways because treatment chosen for one may be ineffective or harmful for another. NICE NG11.
Circadian Rhythm Sleep-Wake Problems
Circadian rhythms coordinate the timing of sleep and wakefulness with environmental light-dark cues and daily activity. A delayed sleep phase means that sleepiness and waking occur later than the desired schedule; irregular sleep-wake rhythm involves fragmented timing across the day and night. Consistent morning light, daytime engagement, predictable routines, and careful assessment of sedating medication may be relevant. Specific genetic syndromes can affect melatonin rhythms, but genetic diagnosis alone is insufficient to determine an individual's sleep timing. Woodford and colleagues, 2021.
A schedule that suits a group residence or school is not automatically identical to the person's optimal sleep timing. Evaluation must consider reasonable accommodations, preferred activities, age, shift schedules of caregivers, and the consequences of imposed wake times. Circadian assessment is strongest when it describes the pattern across multiple days rather than a single difficult night.
Sleep-Disordered Breathing
Obstructive sleep apnea involves repeated narrowing or collapse of the upper airway during sleep, with disrupted ventilation and sleep fragmentation. Symptoms can include habitual snoring, gasping, witnessed pauses, restless sleep, unusual sleeping positions, morning headaches, and excessive daytime sleepiness. Some people present primarily with daytime behavior changes or attention difficulties. Clinical suspicion warrants appropriate medical assessment; a structured bedtime routine cannot treat airway obstruction. American Academy of Pediatrics Down syndrome guidance; Perera and O'Regan, 2024.
Certain associated conditions increase the probability of sleep-disordered breathing through anatomy, muscle tone, obesity, or other mechanisms. Down syndrome is a particularly important example. The American Academy of Pediatrics recommends a sleep study for all children with Down syndrome between ages three and four because caregiver-reported symptoms correlate poorly with polysomnography findings; symptoms also justify assessment at other ages. This syndrome-specific screening recommendation should not be transferred uncritically to every person with intellectual disability. Bull and colleagues, 2022.
Restless Sleep, Movement Disorders, Seizures, and Parasomnias
Some nighttime disturbances reflect restless legs syndrome, periodic limb movement disorder, parasomnias such as sleepwalking, or nighttime seizures. A person who finds it difficult to explain uncomfortable leg sensations may show repeated movement, resistance to bedtime, or distress. Clinicians may investigate iron deficiency in an appropriate clinical context while considering alternative explanations. Video descriptions from trusted observers sometimes help differentiate episodes, although formal sleep or neurologic studies may still be required. Bull and colleagues, 2022; AASM actigraphy guideline.
A sudden stereotyped nighttime event, injury, altered responsiveness, or a new pattern in someone with epilepsy merits prompt medical review. Treating suspected seizures as a bedtime behavior issue delays appropriate investigation. Actigraphy records movement and can assist with sleep timing, but it cannot establish the diagnosis of nocturnal epilepsy or replace electromyography for periodic limb movement disorder. Smith and colleagues, 2018.
Excessive Daytime Sleepiness
Marked daytime sleepiness calls for review of nighttime quantity and quality, respiratory disorders, circadian timing, medication effects, medical illness, and possible hypersomnolence disorders. Sleeping during daytime activity may be wrongly interpreted as disengagement or low motivation. Clinicians should ask whether the person is falling asleep involuntarily, what opportunities for sleep exist, whether sedating medications were recently changed, and whether snoring or fragmented breathing is present. It is especially important to assess changed alertness following illness or medication adjustments. Perera and O'Regan, 2024.
Why Sleep Problems Develop: An Interactive Clinical Model
Medical Discomfort and Physical Health
People with intellectual disability experience familiar causes of disturbed sleep, including dental pain, headaches, constipation, reflux, eczema, urinary symptoms, respiratory disease, and musculoskeletal discomfort. Motor disabilities can complicate positioning and transfers. Some individuals may communicate pain through expressions, movement, altered appetite, new resistance to care, or changes in sleep rather than through conventional verbal descriptions. The appropriate response is an accessible medical assessment of the change, including the person's established ways of signaling discomfort. NICE NG54.
Persistent waking despite a well-organized sleep routine should prompt renewed consideration of missed health conditions. Diagnostic overshadowing occurs when clinicians attribute new symptoms to a pre-existing disability and overlook treatable illness. A change in sleep can be an early clue to physical or psychiatric distress. The relevant question is what has altered in this person's baseline, not whether a sleep disturbance is common in a diagnostic population. NICE NG54.
Neurobiology, Genetic Conditions, and Epilepsy
Neurodevelopmental pathways can influence circadian regulation, sensory processing, arousal, and co-occurring neurologic disease. For instance, sleep research in Smith-Magenis syndrome describes distinctive circadian and melatonin features, while Angelman syndrome is associated with complex arousal and sleep-maintenance complaints. Children and adults with Down syndrome warrant careful attention to obstructive breathing. The same condition can produce different sleep patterns in different individuals, and comorbid illness, environment, and personal routines further modify outcomes. Esbensen and Schwichtenberg, 2016; Woodford and colleagues, 2021.
Seizures, antiseizure medications, sleep deprivation, and daytime drowsiness can interact. Some treatments cause sedation, while others may change sleep architecture or timing. Any medication review should examine the total regimen, clinical indication, and recent changes. Abrupt discontinuation of prescribed antiseizure or psychiatric medication can be dangerous; medication adjustments belong with the treating clinician.
Anxiety, Trauma, and Emotional Health
Worry, separation distress, grief, adverse experiences, depression, and trauma-related hyperarousal may interfere with sleep. These experiences deserve direct inquiry in an accessible format. A person may describe nightmares through pictures, voice output, or simple choices; other symptoms may be evident through changes from normal behavior. Families and staff can contribute observations, while the person's privacy, preferences, and consent remain central. The presence of intellectual disability must never be used to rule out treatable psychiatric conditions. NICE NG54.
The relationship is often reciprocal: poor sleep may worsen emotional regulation and coping, while distress disrupts sleep. Cross-sectional correlations do not establish whether sleep causes challenging behavior, or whether both arise from pain, environment, anxiety, or other conditions. Treatment plans should therefore test plausible contributors and measure changes in several outcomes rather than presuming a single cause. Van de Wouw and colleagues, 2012.
Environment, Relationships, and Daily Structure
Lighting, temperature, excessive noise, nighttime checks, room sharing, lack of privacy, uncomfortable bedding, restrictive schedules, and inconsistent staffing can all shape sleep opportunity. Institutional timetables may produce premature bedtimes or early morning waking. A good plan considers sensory preferences, autonomy, and the physical conditions of the person's bedroom. It also asks whether assistance is required for toileting, repositioning, medication, or comfort and how that help can be delivered with minimal disturbance. NICE NG11.
Daytime activity is part of the sleep environment. Limited opportunities for movement, social participation, outdoor light, and meaningful occupation may weaken predictable day-night patterns. Yet an individual with pain, fatigue, epilepsy, or mobility limitations may need a different activity plan than someone who enjoys vigorous exercise. Person-centered planning combines routines with choice and avoids turning a clinical intervention into forced compliance.
Medication and Substance Effects
Sedating psychotropic agents, certain antiseizure medications, stimulants, analgesics, and other prescriptions can change sleep onset, arousal, sleep duration, or daytime alertness. Timing and drug interactions matter, especially in polypharmacy. Caffeine and other stimulant exposures should be reviewed when relevant. A medication reconciliation includes prescribed agents, over-the-counter products, supplements, doses, and the reasons each was introduced, without assuming that a prescribed sedative treats the underlying cause of insomnia. Perera and O'Regan, 2024.
How to Assess Sleep Problems in Intellectual Disability
Start With the Person and a Baseline History
A sleep assessment begins with the person's own account whenever possible. Clinicians should allow extra processing time, offer easy-read or pictorial questions, invite preferred communication supports, and distinguish assent, capacity for a particular decision, and consent according to the applicable clinical and legal context. Trusted supporters can contribute information about the usual sleep pattern and recent changes. Participation should not require fluent spoken language or conventional diary writing.
An effective history establishes age, the main concern, onset and duration, weekday and weekend sleep timing, sleep opportunity, naps, nighttime observations, breathing symptoms, pain, illnesses, seizures, psychological stressors, relevant life changes, and the current medication schedule. Ask what changed shortly before the difficulty began. Also ask what outcome would matter to the person: fewer painful awakenings, more energy for work, easier mornings, a calmer bedtime, or restored privacy. Such outcomes direct the care plan beyond a simple count of sleeping hours.
Use a Structured Sleep Record
A sleep diary collected over roughly one to two weeks can record bedtime, estimated sleep onset, nocturnal awakenings, wake time, naps, medication changes, distress, and daytime functioning. The duration should fit the situation; longer monitoring may be useful when patterns vary. The person can complete it independently with adapted symbols or collaboratively with supporters. Staff across shifts should use consistent definitions so that records describe sleep rather than differences in how each observer documents behavior.
Caregivers may estimate sleep by listening or looking in, and these observations can miss quiet wakefulness. Conversely, a movement monitor may interpret stillness as sleep. Triangulating reports, behavior patterns, and appropriately chosen measures provides a more defensible assessment than treating any one measurement as infallible. The American Academy of Sleep Medicine supports actigraphy in selected insomnia and circadian rhythm assessments, with conditional recommendations rather than a requirement for all patients. Smith and colleagues, 2018.
Physical Examination and Targeted Investigations
A physical examination and review of clinical history may identify breathing risk, discomfort, weight change, upper-airway findings, anemia risk, medication effects, or neurologic symptoms. Testing follows a clinical question. Overnight polysomnography is appropriate when sleep-disordered breathing or selected other physiological sleep conditions are suspected; actigraphy estimates rest-activity timing and cannot diagnose apnea. A seizure evaluation may require neurologic assessment and appropriately selected electroencephalographic testing. Laboratory tests should be guided by symptoms and risk factors. Bull and colleagues, 2022; Smith and colleagues, 2018.
Sleep clinics should plan for sensory needs, caregiver participation when desired, accessible explanations, and equipment familiarization. A person who finds sensors distressing may benefit from advance visits or demonstrations. Accessibility enables more reliable data and more equitable care. The need for adjustment to a test is a service-design responsibility and should not be treated as failure of the person being assessed.
Diagnostic Reasoning and Differential Diagnosis
Insomnia, circadian rhythm disorder, sleep apnea, restless legs syndrome, parasomnia, nocturnal epilepsy, medication-induced sleep change, and psychiatric or medical illness involve different mechanisms and investigations. A person can have more than one condition. New nighttime screaming might reflect pain, a parasomnia, fear, trauma, or seizure phenomena; the surrounding features and timeline determine the evaluation. Habitual snoring with daytime sleepiness demands attention to breathing, even if the bedroom schedule also needs improvement.
Sleep screening instruments can organize questions, but diagnostic labels require appropriate clinical assessment and should not be assigned on the basis of a caregiver questionnaire alone. Normative data for general-population questionnaires may not transfer to every communication or neurodevelopmental profile. Similarly, an intellectual disability diagnosis does not establish a sleep-wake disorder. It is possible to have sleep concerns requiring support without meeting full diagnostic criteria for insomnia disorder.
What Helps: Evidence-Based and Individualized Care
Treat Identified Medical and Psychological Contributors
Care is most effective when matched to cause. Clinicians treat obstructive sleep apnea according to sleep medicine assessment, address pain or constipation when present, review medication effects with prescribers, and investigate possible nocturnal seizures or mental health symptoms. A person who awakens from breathing interruption needs a respiratory treatment pathway, while someone distressed by nighttime noise may need environmental modification. Behavioral recommendations should not displace medical evaluation when clinical warning signs are present. Perera and O'Regan, 2024; NICE NG54.
The person and supporters should agree on practical measures of success. Outcomes may include daytime alertness, reductions in gasping episodes after treatment, ability to participate in preferred activities, fewer unwanted nighttime disruptions, family wellbeing, and the person's own satisfaction. Short-term improvements in a diary matter, but sustained benefit, tolerability, and quality of life determine whether care is actually useful.
Bedtime Routines and Behavioral Interventions
Structured bedtime routines offer predictable cues: adequate time to wind down, a quiet and comfortable environment, preferred calming activities, and consistent but flexible scheduling. For people who require support, visual schedules, plain-language prompts, and predictable staff responses can help. Any functional assessment should identify why someone wakes, leaves the bed, calls for support, or resists bedtime; these actions may communicate fear, pain, loneliness, toileting needs, or legitimate preferences. A successful plan accommodates those needs instead of merely attempting to suppress the behavior. NICE NG11.
A systematic review and meta-analysis of behavioral interventions in people with intellectual disability identified seven studies involving 169 participants. The pooled studies suggested improvement in sleep onset and maintenance, but the evidence combined group and single-case designs, varied procedures, and inconsistent follow-up. It supports carefully tailored behavioral strategies while leaving uncertainty about which specific components produce durable benefit for which individuals. Priday and colleagues, 2017.
For persistent insomnia, clinicians may adapt components of cognitive behavioral therapy for insomnia, including stabilizing sleep opportunity, identifying conditions that maintain wakefulness, and addressing anxiety around sleep. The American College of Physicians recommends CBT-I as first-line treatment for adults with chronic insomnia in the general population. That recommendation has a substantially broader evidence base than ID-specific trials, so adaptations for intellectual disability should be developed collaboratively and monitored rather than presumed equally effective without testing. Qaseem and colleagues, 2016; Shanahan and colleagues, 2019.
Certain conventional insomnia techniques need caution when a person has epilepsy, mobility limitations, high fall risk, substantial daytime sleepiness, or requires assistance during the night. Rigid sleep restriction, withholding necessary comfort, and coercive bedtime practices can undermine safety or autonomy. A clinician experienced in behavioral sleep medicine and disability-responsive practice can select proportionate, acceptable alternatives. Physical safety and the individual's expressed choices remain central.
Light, Activity, and Circadian Support
Regular exposure to daylight, enjoyable daytime activities, and an evening environment conducive to sleep can help coordinate sleep timing. In suspected circadian rhythm conditions, clinician-guided light timing and stable schedules may have a place. A person who has limited outdoor access, visual impairment, or shift-based assistance may require adjustments. The objective is a workable rhythm matched to the individual's biology and circumstances, not universal compliance with a fixed bedtime. Smith and colleagues, 2018.
Changes should be introduced in an observable way and evaluated over several weeks when feasible. If morning light is increased and bedtime shifts earlier simultaneously, it may be difficult to attribute benefit to either element. A collaborative plan can prioritize one or two feasible changes, document the pattern, and adjust according to results without subjecting the person to excessive monitoring.
Melatonin: Evidence, Limits, and Clinical Oversight
Melatonin is a hormone involved in circadian signaling and is also used as a medication or supplement for certain sleep difficulties. Its effects depend on the formulation, timing, individual physiology, and sleep problem being treated. It should never be assumed to cure sleep apnea, pain, anxiety, or nighttime seizures. The NICE guidance addressing children and adults with learning disabilities whose behavior challenges recommends considering behavioral approaches first; when problems persist, medication decisions require specialist involvement, continued nonpharmacological strategies, and review. The guideline mentions melatonin as an option when medication is clinically justified. Its wording and licensing caveats reflect the UK context and should not be treated as universal prescribing law. NICE NG11.
A 2009 meta-analysis of nine placebo-controlled randomized trials in people with intellectual disability, totaling 183 participants, reported improvements in sleep latency and total sleep time, with considerable limitations associated with older, relatively small studies. A later major randomized trial among 146 children with neurodevelopmental disorders found faster sleep onset but only a modest increase in total nighttime sleep and an earlier waking time; behavior and family-function changes were not statistically persuasive. These studies show why shorter time to fall asleep cannot be treated as identical to a large improvement in total sleep or daytime wellbeing. Braam and colleagues, 2009; Gringras and colleagues, 2012.
In adults specifically, a systematic review found only nine intervention studies with 97 participants across diverse approaches; most had serious or critical risk of bias, while the single low-risk study assessed melatonin. Treatment effects and long-term safety therefore remain insufficiently established for many adult populations and combinations of medications. Selection, dose, formulation, timing, interactions, monitoring, and continuation should be discussed with a qualified clinician who understands the person's clinical history. The evidence does not support recommending a universal dose in an encyclopedia article. Shanahan and colleagues, 2019.
Hypnotics, Sedating Drugs, and Polypharmacy
Medication used primarily to sedate a person can produce next-day drowsiness, impair balance, interact with other drugs, and obscure conditions that caused the sleep problem. Some drugs have specific approved indications, while other use is off-label and dependent on jurisdiction. Clinical decisions require a clear target symptom, expected duration, benefit-risk discussion, review date, and a plan for recognizing adverse effects. A medicine prescribed for epilepsy, mood, psychosis, or another condition should be reviewed according to that indication; an incidental sedating effect is not the same as proven insomnia treatment. NICE NG11; Qaseem and colleagues, 2016.
When sleep medication appears ineffective, the next step is renewed assessment of the diagnosis, regimen, timing, environmental context, and outcome measures. Adding another sedative without this analysis may increase cumulative harms. Changes should be coordinated by prescribers, especially when epilepsy or other neurologic conditions complicate care.
Tailoring Support Across the Life Span
Children and Adolescents
A child's need for comforting adults, sensory preferences, communication development, school transport times, and medical conditions all affect sleep. Families may be balancing demanding overnight care with daytime work, and a sleep plan should address caregiver wellbeing without compromising the child's comfort or safety. Clinical teams can coordinate pediatric care, sleep medicine, developmental specialists, and schools when difficulties persist. Where the child has Down syndrome, follow syndrome-specific sleep-apnea assessment recommendations in addition to general sleep history. Bull and colleagues, 2022.
Transition through adolescence brings changes in circadian timing, privacy, autonomy, and who delivers assistance. The young person's preferences should guide their bedroom environment and daily schedule as far as practical. Teaching accessible sleep-management skills can help, while parents and professionals remain responsive to medical needs and the possibility that a new problem represents illness rather than ordinary adolescent change.
Adults in Independent, Family, and Residential Settings
Adults may share housing, live with family, receive supported living services, or live independently. Sleep plans therefore depend on how and when assistance is available. Residential providers should examine shift transitions, bright nighttime lighting, staff-initiated waking, unnecessary checks, bedroom choice, and respect for privacy. People should be able to describe what a restful night means to them and identify whom to contact when symptoms persist. Perera and O'Regan, 2024.
A support plan must survive staff changes. It should distinguish routine assistance from escalation signs, document individualized communication, specify outcomes, and explain who will review the plan. Maintaining continuity across primary care, psychiatry, neurology, and sleep services is particularly important when many medications and diagnoses are involved. Families and staff can contribute reliable observations while the person remains the central participant in decisions.
Older Adults and Changing Health
With aging, sleep may be affected by pain, cardiopulmonary disease, medication burden, mood disorders, mobility changes, and neurocognitive decline. In people with certain genetic conditions, age-related health patterns warrant additional surveillance, but a new change in sleeping habits cannot by itself diagnose dementia. Investigate treatable causes before attributing decline in sleep or alertness to aging. Research on older adults with intellectual disability remains comparatively limited, and evidence derived from younger groups does not automatically answer questions for later life. Van de Wouw and colleagues, 2012; Perera and O'Regan, 2024.
A Practical Clinical Care Pathway
A person-centered pathway starts by clarifying the specific sleep concern and meaningful daytime effects, establishing the person's usual pattern, and asking how they prefer to communicate. The next stage reviews respiratory symptoms, medical discomfort, neurologic events, psychiatric changes, medication exposures, environmental conditions, and daytime opportunities for activity. Select a sleep diary or other measure appropriate to the person; investigate possible apnea, seizures, or other sleep disorders through relevant services. Then agree on one or more targeted interventions and monitor both sleep and quality of life. This sequence provides a practical synthesis of current guidelines and reviews rather than a separately validated diagnostic algorithm. NICE NG11; Smith and colleagues, 2018.
Urgent medical evaluation is warranted when nighttime symptoms involve severe breathing difficulty, prolonged or recurrent convulsive episodes, significant injury, rapidly reduced consciousness, or other acute warning signs. New loud snoring with witnessed apneas, marked daytime sleepiness, sudden unexplained nighttime events, or significant loss of previously established abilities should prompt timely assessment. The emergency response depends on the severity of symptoms and local services. A behavioral sleep plan is never a substitute for urgent care.
Routine follow-up should revisit the same outcomes measured initially: total sleep opportunity, onset latency, awakenings, sleepiness, participation, distress, treatment adverse effects, and the person's assessment of benefit. A change in staff impressions without a change in objective or person-reported functioning may merit further inquiry. A treatment can also reduce nighttime calls by suppressing requests while leaving pain untreated; this is not evidence of improved sleep health.
What the Research Can and Cannot Establish
Evidence is established that people with intellectual and developmental disabilities experience a heterogeneous range of sleep difficulties, that certain associated genetic and medical conditions carry identifiable sleep-related risks, and that careful assessment must address coexisting disease and environmental circumstances. Syndrome-specific recommendations for sleep-disordered breathing, including the AAP's Down syndrome guidance, are clinically actionable. Bull and colleagues, 2022; Agar and colleagues, 2021.
Evidence is promising but more limited for particular behavioral sleep interventions in intellectual disability. Small trials and single-case studies provide useful signals, yet participants, settings, outcomes, and intervention components differ considerably. Melatonin has evidence for improving sleep onset in selected populations, while magnitude of total-sleep benefit, long-term outcomes, and transferability to specific adult subgroups remain less certain. Adult intervention research is notably sparse and biased toward small samples. Priday and colleagues, 2017; Braam and colleagues, 2009; Shanahan and colleagues, 2019.
Prevalence figures remain contested at the level of exact comparability because sleep-problem definitions and measurement instruments differ. Evidence about whether sleep disturbance causes challenging behavior is also limited by observational designs and confounding factors. More longitudinal studies, adapted patient-reported measures, appropriately powered trials, and participatory research that includes the priorities of people with intellectual disability would improve clinical guidance. Van de Wouw and colleagues, 2012; Perera and O'Regan, 2024.
Common Questions About Sleep and Intellectual Disability
Is Poor Sleep an Expected Part of Intellectual Disability?
No single sleep pattern defines intellectual disability. The probability of sleep problems is elevated in various studied populations, but many causes are treatable or responsive to changes in care. Clinicians should evaluate persistent complaints in the same serious manner as for other people, while adapting communication and accessibility. AAIDD; Perera and O'Regan, 2024.
Should Every Person With Intellectual Disability Have a Sleep Study?
No universal polysomnography recommendation applies to all intellectual disability diagnoses. Sleep studies are selected according to suspected conditions and particular syndrome-specific guidance. A key exception is the AAP recommendation for children with Down syndrome between three and four years of age, even when caregivers do not report symptoms. Bull and colleagues, 2022.
Can Sleep Problems Explain Increased Irritability or Challenging Behavior?
They may contribute, but the relationship is not diagnostically specific. New distress, withdrawal, agitation, or difficulty participating should lead to assessment of sleep alongside pain, mental health, medications, unmet needs, and environmental changes. A functional assessment can help identify maintaining factors, while careful review prevents physical or psychiatric illness from being overlooked. NICE NG11; NICE NG54.
Is Melatonin the First Treatment to Try?
A targeted evaluation and appropriate nonpharmacological care generally come first, particularly when sleep difficulty might be caused by medical disease or the person's environment. Melatonin may be considered for selected problems under qualified clinical supervision. Its effectiveness depends on the outcome measured, and its benefits do not extend uniformly to every sleep complaint. NICE NG11; Gringras and colleagues, 2012.
What If the Person Cannot Explain Their Sleep Problem Verbally?
Clinicians can adapt questions to the person's preferred means of communication and use careful observation from supporters alongside sleep diaries or other tools. Comparing the current pattern with the person's established baseline can reveal change. Supporters provide evidence without replacing the person's own participation wherever participation is possible. NICE NG54.
What Counts as Successful Sleep Care?
Meaningful success combines improved sleep or treatment of a specific sleep disorder with better daytime comfort, alertness, autonomy, participation, and quality of life. It should be defined with the person and reassessed over time. A quieter night for staff is valuable only insofar as it corresponds with the individual's safety, sleep health, and preferences.
Related Articles
Cluster Intellectual and Developmental Disabilities — Scientific overview of intellectual functioning, adaptive skills, health and support across the life span.
Mental Health Problems in People With Intellectual Disability: Recognition and Care — Assessment of co-occurring distress and psychiatric conditions with accessible clinical methods.
Challenging Behavior in Intellectual Disability: Causes, Assessment, and Support — Functional assessment, health contributors, and ethical approaches to behavioral support.
Autism and Intellectual Disability in Adults: Differences and Support — Related distinctions and support considerations in an adjacent research cluster.
Antipsychotic and Psychotropic Medication in Intellectual Disability: Benefits and Risks — Clinical prescribing issues when behavior or co-occurring mental disorder is present.
References
Agar, G., Brown, C., Sutherland, D., Coulborn, S., Oliver, C., and Richards, C. (2021). Sleep disorders in rare genetic syndromes: A meta-analysis of prevalence and profile. Molecular Autism, 12, 18. DOI: 10.1186/s13229-021-00426-w.
American Association on Intellectual and Developmental Disabilities (AAIDD). (2021). Defining criteria for intellectual disability. AAIDD official definition.
Braam, W., Smits, M. G., Didden, R., Korzilius, H., van Geijlswijk, I. M., and Curfs, L. M. (2009). Exogenous melatonin for sleep problems in individuals with intellectual disability: A meta-analysis. Developmental Medicine and Child Neurology, 51, 340–349. DOI: 10.1111/j.1469-8749.2008.03244.x.
Bull, M. J., Trotter, T., Santoro, S. L., and the Council on Genetics. (2022). Health supervision for children and adolescents with Down syndrome. Pediatrics, 149(5), e2022057010. DOI: 10.1542/peds.2022-057010.
Esbensen, A. J., and Schwichtenberg, A. J. (2016). Sleep in neurodevelopmental disorders. International Review of Research in Developmental Disabilities, 51, 153–191. DOI: 10.1016/bs.irrdd.2016.07.005.
Gringras, P., Gamble, C., Jones, A. P., and colleagues. (2012). Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial. BMJ, 345, e6664. DOI: 10.1136/bmj.e6664.
National Institute for Health and Care Excellence (NICE). (2015). Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges (NG11). Official recommendations.
National Institute for Health and Care Excellence (NICE). (2016). Mental health problems in people with learning disabilities: Prevention, assessment and management (NG54). Official recommendations.
Perera, B., and O'Regan, D. (2024). Sleep disorders in adults with intellectual disability: Current status and future directions. Current Treatment Options in Neurology, 26, 385–392. Official journal article.
Priday, L. J., Byrne, C., and Totsika, V. (2017). Behavioural interventions for sleep problems in people with an intellectual disability: A systematic review and meta-analysis of single case and group studies. Journal of Intellectual Disability Research. DOI: 10.1111/jir.12265.
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., and Denberg, T. D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125–133. DOI: 10.7326/M15-2175.
Shanahan, P. J., Palod, S., Smith, K. J., Fife-Schaw, C., and Mirza, N. (2019). Interventions for sleep difficulties in adults with an intellectual disability: A systematic review. Journal of Intellectual Disability Research, 63(5), 372–385. DOI: 10.1111/jir.12587.
Smith, M. T., McCrae, C. S., Cheung, J., Martin, J. L., Harrod, C. G., Heald, J. L., and Carden, K. A. (2018). Use of actigraphy for the evaluation of sleep disorders and circadian rhythm sleep-wake disorders: An American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine, 14(7), 1231–1237. DOI: 10.5664/jcsm.7230.
Van de Wouw, E., Evenhuis, H. M., and Echteld, M. A. (2012). Prevalence, associated factors and treatment of sleep problems in adults with intellectual disability: A systematic review. Research in Developmental Disabilities. Publisher article.
Woodford, E. C., McLay, L., France, K. G., Blampied, N. M., Gibbs, R., Swan, C. E., and Eggleston, M. (2021). Endogenous melatonin and sleep in individuals with rare genetic neurodevelopmental disorders: A systematic review. Sleep Medicine Reviews, 57, 101433. DOI: 10.1016/j.smrv.2021.101433.